61 – 70 of 114
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Development and In Vitro Characterization of a Gemcitabine-loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Characterization of histone-related chemical modifications in formalin-fixed paraffin-embedded and fresh-frozen human pancreatic cancer xenografts using LC-MS/MS
(
- Contribution to journal › Article
-
Mark
Hemorrhage after Major Pancreatic Resection: Incidence, Risk Factors, Management, and Outcome.
(
- Contribution to journal › Article
-
Mark
Outcome and evaluation of prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma
(
- Contribution to journal › Article
-
Mark
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine
(
- Contribution to journal › Article
-
Mark
Impact of body constitution on complications following pancreaticoduodenectomy : A retrospective cohort study
(
- Contribution to journal › Article
- 2016
-
Mark
Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas
(
- Contribution to journal › Article
-
Mark
Pattern of tumour growth of the primary colon cancer predicts long-term outcome after resection of liver metastases
(
- Contribution to journal › Article
-
Mark
Safety of pancreatic resection in the elderly : a retrospective analysis of 556 patients
(
- Contribution to journal › Article